-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Hepatic Carcinoma Vaccine in Liver Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Hepatic Carcinoma Vaccine in Liver Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Hepatic Carcinoma Vaccine in Liver Cancer Drug Details: The vaccine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – FPA-150 in Epithelial Ovarian Cancer
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.FPA-150 in Epithelial Ovarian CancerDrug Details:FPA-150 is under development for the treatment of advanced or metastatic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ESP-01 in Gastrointestinal Stromal Tumor (GIST)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ESP-01 in Gastrointestinal Stromal Tumor (GIST) Drug Details: ESP-01 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ESP-01 in Endometrial Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ESP-01 in Endometrial Cancer Drug Details: ESP-01 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TVI-Brain-1 in Recurrent Glioblastoma Multiforme (GBM)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TVI-Brain-1 in Recurrent Glioblastoma Multiforme (GBM) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TVI-Brain-1 in Recurrent Glioblastoma Multiforme (GBM) Drug Details: TVI-Brain-1 is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vorasidenib Citrate in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vorasidenib Citrate in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Vorasidenib Citrate in Solid Tumor Drug Details: Vorasidenib (AG-881) is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Docetaxel in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Docetaxel in Gastric Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Docetaxel in Gastric Cancer Drug Details: Docetaxel (nano-formulation) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (linagliptin + metformin) SR in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (linagliptin + metformin) SR in Type 2 Diabetes report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (linagliptin + metformin) SR in Type 2...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Vaxinia in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Vaxinia in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.VAXINIA in Solid Tumor Drug Details:VAXINIA (CF33+hNIS) is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Lirentelimab in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Lirentelimab in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.Lirentelimab in Atopic Dermatitis (Atopic Eczema) Drug Details: Lirentelimab (AK002) is...